Copyright
©The Author(s) 2025.
World J Clin Pediatr. Sep 9, 2025; 14(3): 102309
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.102309
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.102309
Table 1 Baseline characteristics and characteristics of the examined cases, n (%)/mean ± SD/median (IQR)
Characteristics | Total (n = 97) |
Age on intubation (days) | |
Median (IQR) | 1 (1–2) |
Range | 1–10 |
Intubation since birth | |
Yes | |
65 (67.0) | |
No | 32 (33.0) |
Sex | |
Male | 66 (68.0) |
Female | 31 (32.0) |
Birth weight (kg) | |
mean ± SD | |
2.84 ± 0.45 | |
Range | 1.89–4.5 |
Weight for age | |
Appropriate for GA (2.5 kg or more) | |
76 (78.4) | |
Small for GA (less than 2.5 kg) | 21 (21.6) |
Mode of delivery | |
Cesarean section | 83 (85.6) |
Normal vaginal delivery | 14 (14.4) |
APGAR score at 1 minute | |
Median (IQR) | 3 (1–3) |
Range | 0-7 |
APGAR score at 5 minutes | |
Median (IQR) | 7 (6–8) |
Range | 2–10 |
Resuscitation | |
Positive pressure ventilation | 35 (36.1) |
Tactile stimulation | 12 (12.4) |
Intubation | 50 (51.5) |
Table 2 Pepsin in sample A, B, and C of the studied cases, n (%)
Characteristics | Total (n = 97) |
Sample A ETA pepsin (ng/mL) | |
Median (IQR) | 0.87 (0.11–2.58) |
Range | 0.01–31 |
Pepsin detection in sample A | |
Not detected | 21 (21.6) |
Detected | 76 (78.4) |
Sample B ETA pepsin (ng/mL) | |
Median (IQR) | 0.84 (0.23–2.68) |
Range | 0.01–12.5 |
Pepsin detection in sample B | |
Not detected | 18 (18.8) |
Detected | 78 (81.3) |
Sample C ETA pepsin (ng/mL) | |
Median (IQR) | 0.43 (0.05–1.63) |
Range | 0.01–8.68 |
Pepsin detection in sample C | |
Not detected | 22 (31.9) |
Detected | 47 (68.1) |
Table 3 Relation of pepsin detection in sample A, B, and C with endotracheal aspirate culture of the studied cases, n (%)
Pepsin detection in sample A | Test value | P value | |||
No detection (n = 21) | Detected (n = 76) | ||||
ETA culture | Not done | 5 (23.8) | 8 (10.5) | 4.0961 | 0.129 |
No growth | 10 (47.6) | 30 (39.5) | |||
Positive | 6 (28.6) | 38 (50) | |||
Pepsin detection in sample B | |||||
ETA culture | Not done | 2 (11.1) | 11 (14.1) | 1.0391 | 0.595 |
No growth | 6 (33.3) | 34 (43.6) | |||
Positive | 10 (55.6) | 33 (42.3) | |||
Pepsin detection in sample C | |||||
ETA culture | Not done | 3 (13.6) | 4 (8.5) | 0.506 | 0.776 |
No growth | 9 (40.9) | 22 (46.8) | |||
Positive | 10 (45.5) | 21 (44.7) |
Table 4 Duration of hospital stay and outcome of the studied cases, n (%)
Characteristics | Total (n = 97) |
Duration of hospital stay (days) | |
Median (IQR) | 15 (10–22) |
Range | 4–35 |
Outcome | |
Died | 38 (39.2) |
Discharged | 59 (60.8) |
Table 5 Relation of pepsin detection in sample B with pepsin levels and pepsin detection in sample A and sample C of the studied cases, n (%)
Pepsin detection in sample B | Test value | P value | ||
No detection (n = 18) | Detected (n = 78) | |||
Sample A ETA pepsin (ng/mL) | -1.314 | 0.189 | ||
Median (IQR) | ||||
0.48 (0.02–1.9) | 0.94 (0.28–2.67) | |||
Range | 0.01–7.27 | 0.01–31 | ||
Pepsin detection in sample A | 3.752 | 0.053 | ||
No detection | ||||
7 (38.9) | 14 (17.9) | |||
Detected | 11 (61.1) | 64 (82.1) | ||
Sample C ETA pepsin (ng/mL) | -1.794 | 0.073 | ||
Median (IQR) | ||||
0.03 (0.01–1.43) | 0.51 (0.06–1.73) | |||
Range | 0.01–4.02 | 0.01–8.68 | ||
Pepsin detection in sample C | 4.494 | 0.034a | ||
No detection | ||||
7 (58.3) | 15 (26.8) | |||
Detected | 5 (41.7) | 41 (73.2) |
Table 6 Correlation of pepsin in sample A, B and C with other studied parameters among the studied cases
Sample A ETA pepsin (ng/mL) | Sample B ETA pepsin (ng/mL) | Sample C ETA pepsin (ng/mL) | ||||
r | P value | r | P value | r | P value | |
Age on intubation (days) | -0.027 | 0.791 | 0.082 | 0.429 | -0.170 | 0.164 |
Birth weight | 0.010 | 0.919 | 0.155 | 0.132 | -0.137 | 0.261 |
APGAR score at 1 minute | -0.082 | 0.426 | 0.027 | 0.795 | 0.008 | 0.951 |
APGAR score at 5 minutes | -0.020 | 0.847 | -0.062 | 0.549 | 0.087 | 0.476 |
Proton pump inhibitor (days) | -0.004 | 0.981 | 0.054 | 0.748 | -0.049 | 0.816 |
Prokinetic drugs (days) | 0.005 | 0.976 | -0.050 | 0.784 | -0.230 | 0.259 |
Duration of MV (days) | 0.080 | 0.438 | 0.130 | 0.208 | -0.129 | 0.292 |
FiO2 | 0.166 | 0.104 | 0.203 | 0.047a | 0.193 | 0.112 |
Amount of feeding (mL/day) | -0.210 | 0.039a | -0.234 | 0.022a | -0.267 | 0.027a |
Duration of hospital stay (days) | 0.031 | 0.766 | 0.288 | 0.004a | 0.559 | 0.000a |
- Citation: Elrefaee A, Abdel-Razek ARA, Abdelkhalek ZS, Samaan P, Kamal AF. Incidence of gastro-esophageal reflux disease in mechanically ventilated full-term Egyptian neonates by detection of pepsin in endotracheal aspirate. World J Clin Pediatr 2025; 14(3): 102309
- URL: https://www.wjgnet.com/2219-2808/full/v14/i3/102309.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.102309